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Abstract
Background: Acute Toxoplasma gondii infection during pregnancy represents a risk for congenital disease, especially
among women without previous exposure to infection. There is, however, a paucity of information about the
epidemiology of T. gondii infection in pregnant women in Tanzania. This study aimed to determine the seroprevalence
of T. gondii infection and associated demographic, clinical, and behavioral risk factors in pregnant women attending
ante-natal clinic (ANC) at Kilimanjaro Christian Medical Center (KCMC), a referral medical center in Northern Tanzania.
Methods: A hospital-based cross-sectional study was carried out from 1 February to 30 April 2017. Data on maternal
demographic characteristics, obstetric history, knowledge, and practices related to T. gondii infection were collected
from 254 pregnant women attending antenatal care at KCMC. A sample of 4 mL of blood was collected from each
participant and sera prepared from each sample. Serum samples were tested for the presence of specific T. gondii IgG
and IgM antibodies by indirect Enzyme-Linked Immunosorbent Assay (ELISA). DNA was extracted from whole blood for
polymerase chain reaction (PCR) testing, targeting the DNA sequence coding for the Internal Transcribed Spacer 1
(ITS1).
Results: The overall T. gondii seroprevalence, including both IgM- and IgG-positive individuals, was 44.5%. Of the 254
tested women, 102 and 23 were seropositive for T. gondii-specific IgG and IgM antibodies respectively and
113 individuals had antibodies of either or both classes. All IgM-positive samples were also tested by PCR,
and all were negative. The majority (90%) of the women surveyed had never heard about toxoplasmosis.
Consumption of raw vegetables [aOR = 0. 344; 95% CI 0.151–0.784; p = 0.011] and having regular contact with
soil [aOR = 0.482; 95% CI 0.268–0.8681; p = 0.015] were both associated with T. gondii antibody status. Inverse
relationships with probability of T. gondii exposure were observed, such that these practices were associated
with reduced probability of antibody detection.
Conclusion: Based on serology results, we report widespread exposure to T. gondii infection among pregnant
women attending ANC in KCMC. The complex interaction of risk factors for T. gondii infection needs to be
studied in larger longitudinal studies.
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Background
Toxoplasmosis is a globally distributed disease caused by
Toxoplasma gondii, a protozoan parasite that belongs to
the phylum Apicomplexa [1, 2]. It is estimated to infect
more than one third of the world population and to be
responsible for 1.2 million disability-adjusted life years
(DALYs) annually [3]. T. gondii has a complex multi-host
lifecycle. Humans are infected by this parasite mainly by
ingesting food or water that is contaminated with oo-
cysts shed by cats or by eating undercooked or raw meat
containing tissue cysts [4, 5]. One of the major conse-
quences of pregnant women becoming infected by T.
gondii is vertical transmission to the fetus. Although
rare, congenital toxoplasmosis can cause severe neuro-
logical or ocular disease (leading to blindness), as well as
cardiac and cerebral anomalies in the newborn [6, 7].
Limitations in diagnostic techniques in less developed
countries hinder the implementation of effective routine
screening strategies.
The main diagnostic tests for T. gondii infection are
serology for the detection of T. gondii-specific IgM and
IgG antibodies, which indicate previous exposure. Con-
firmation of current infection is made by molecular
tests, most commonly PCR [6, 8]. Maternal-fetal trans-
mission usually occurs when the mother acquires a new
infection just prior to or during pregnancy. The risk of
infection to the fetus is low during early pregnancy but
increases towards parturition. However, the earlier the
fetus is infected, the greater the effects to the fetus and
newborn [9]. This underscores the need for early diagno-
sis and appropriate treatment as the most reliable ways
of reducing the risk of trans-placental transmission and
subsequent sequelae in the newborn [10, 11]. Previous
studies involving pregnant women attending antenatal
clinics (ANC) indicate that the seroprevalence of T. gon-
dii exposure in pregnant women varies substantially be-
tween and within countries. Data from Europe show a
wide range of prevalence of T. gondii exposure in preg-
nant women across countries as measured by serology,
with seroprevalence values from 9 to 67% [12–16].
In previous seroprevalence studies in Asian countries,
the reported seroprevalence of T. gondii infection in
pregnant women was 41.8% in India [6], 41% in Iran
[16], and 49% in Malaysia [17]. In Africa, there have
been relatively few studies of T. gondii prevalence. Sero-
prevalence values of 18.7% to 46.0% have been reported
in Mozambique [18, 19], 30.0% in Benin [20], 40.8% in
Nigeria [21], and 20.3% in Burkina Faso [22]. Previously
identified risk factors for T. gondii infection include eat-
ing undercooked meat, warm and humid climates, drink-
ing of unboiled contaminated water, and keeping a cat
[5, 13, 23, 24]. There have only been a small number of
previously published studies of toxoplasmosis in preg-
nant women in Tanzania [5, 25–28]. This cross-sectional
study was conducted to determine the seroprevalence
and identify risk factors for T. gondii exposure in
pregnant women attending ANC at KCMC, in Moshi
Town, Tanzania.
Methods
Study site and design
This was a cross-sectional, hospital-based study con-
ducted in the period from 1 February to 30 April 2017
at the KCMC. KCMC is a tertiary university teaching
hospital in Moshi town in Kilimanjaro region. It serves
as a zonal referral hospital for five northern regions of
Tanzania, serving about 15 million people from six re-
gions: Tanga, Kilimanjaro, Arusha, Manyara, Singida,
and Dodoma. As a referral medical center, it also serves
patients from other regions of the country and neighbor-
ing countries. The major economic activities in the re-
gion include agriculture, horticulture, trading, tourism,
and livestock keeping. Kilimanjaro region is character-
ized by a hot and wet climate, characteristics which have
been documented to favor T. gondii oocyst survival. In
addition, it is a tradition that residents of the region are
heavy consumers of roasted meats (beef, chicken, and
pork) [5, 29, 30], posing a risk for ingesting infective
parasite tissue cysts from infected animals [4, 5, 13, 17].
Sample size
The minimum sample size for seroprevalence determin-
ation was estimated using the Epi Tools online sample
size calculator using the formula [Z2·(p)·(1 − p)]/c2,
where Z = 1.96 for 95% confidence level (CI), p = ex-
pected true proportion of 20.0%, and c =minimal toler-
able error at 95% CI (0.05). Computing with the above
formula gives a minimum sample size of 246. This study
enrolled 254 pregnant women.
Study population
The study population for this study consisted of preg-
nant women who were 18 years old and above who were
seeking routine antenatal care (ANC) at KCMC. The
study excluded pregnant women who were below 18
years old, those who declined to participate, or those di-
agnosed with any other disease that needed immediate
medical attention. Pregnant women who met study cri-
teria were consecutively enrolled in the study until the
desired sample size was reached.
Data collection
Data on all study participants were obtained using a
structured questionnaire through face to face interview
(see SI file). The questionnaire used in this study was de-
veloped by investigators, with a few questions adopted
from other studies [24]. Validity and reliability of the
questionnaire were determined. It was first piloted on
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ten respondents before the actual study and these re-
spondents were excluded during actual data collection
and analysis. Validity and reliability were determined by
using computer software IBM SPSS Version 20. In
addition, two experts in the field of survey design ap-
proved the quality of questionnaire. After the pre-test,
adjustments in phrasing were made.
Information collected for every participant included
demographic data, obstetrical information, knowledge
about Toxoplasmosis, and practices considered likely to
be associated with T. gondii infection such as residential
place (urban versus rural), education level, regular ex-
posure to soil, owning cat, source of water, and con-
sumption of raw vegetables. All obstetrical information
gathered by questionnaire was also confirmed from
medical files for accuracy for which prior consent was
sought from participating mothers. Patients with mis-
matching information (in questionnaire and medical
files) were excluded from the study. Before interviews,
the questionnaire was pre-tested with 10 pregnant
women at Mawenzi Regional Referral Hospital and
Majengo dispensary to test the validity and relevance of
questions. No personal identifiers were included in data
collection forms.
Blood sample collection and storage
For each consenting participant, 4 mL of venous blood
was collected using a sterile disposable syringe. Two mil-
liliters of each sample was placed into a serum separator
tube (BD Vacutainer®, NJ, USA) and EDTA coated vacu-
tainer tube respectively. Serum separator tubes were left
at room temperature for about 10 min before serum was
separated by centrifugation at 2000×g for 10 min in a re-
frigerated centrifuge and serum stored at − 20 °C before
serological tests. Whole blood samples were stored at 4 °
C until DNA extraction for PCR testing.
Detection of T. gondii-specific IgM and IgG antibody by
Enzyme-Linked Immunosorbent Assay (ELISA)
Detection of T. gondii-specific IgM and IgG was per-
formed using commercial EUROIMMUN ELISA kits
(EUROIMMUN®, Lübeck, Germany) as per the manufac-
turer’s instructions. The absorbance value for each sample
and control samples was obtained using a bichromatic
spectrophotometer (BioTek®, CA, USA) at 450 nm. Results
were defined semi-quantitatively by calculating a ratio of
the extinction value for test samples (optical density) to
the extinction value of the calibrator positive and negative
control sera. Cut points used were < 0.8 for negative, ≥ 0.8
to < 1.1 for equivocal, and ≥ 1.1 for positive result for both
T. gondii-specific IgG and IgM ELISA as per the manufac-
turer’s instructions. Seropositivity was reported if samples
were positive for T. gondii-specific IgM or IgG posi-
tive or both.
Toxoplasma gondii polymerase chain reaction (PCR)
DNA extraction
DNA was extracted from samples collected from partici-
pants who were T. gondii-specific IgM positive by
ELISA. Total DNA was extracted from whole blood
stored with EDTA using the DNeasy Blood & Tissue kits
(Qiagen, Valencia, CA). Two hundred microliters of
whole blood was lysed with Proteinase K in QIAamp
Buffer AL. The purified DNA was then eluted in 200 μL
Buffer AE following the manufacturer’s instructions.
Nested PCR
The PCR amplified DNA sequence coding for the In-
ternal Transcribed Spacer 1 (ITS1), following a previ-
ously described protocol with slight modifications [28].
The PCR assays were performed using a Tetrad2 Peltier
thermocycler (BIO-RAD). Briefly, the primers used in
the first round of the PCR (external primers) were as
previously described [31]. The forward primer (NN1) se-
quence was 5′-TCAACCTTTGAATCCCAA-3′, and the
reverse primer (NN2) sequence was 5′-CGAGCCAAG
ACATCCATT-3′. During the first round, 2 μL of the
sample DNA extract was mixed with 10 μl of 2× master
mix (Promega, Madison, WI, USA) a premixed PCR
amplification buffer, 1 μl of each external primer (NN1
And NN2), and 6 μl of reagent grade H2O making a final
reaction volume of 20 μl. Thermal amplification condi-
tions were 5 min at 95 °C followed by 35 cycles of de-
naturation at 95 °C for 1 min, annealing at 55 °C for 1
min and extension at 72 °C for 1 min with an elongation
step of 5 min at 72 °C.
For the second round PCR, 2 μl of the first-round PCR
product, diluted to 1:5 with molecular grade water (Qia-
gen, Valencia, CA) was used as the template for the
second-round PCR in a total volume of 20 μl under the
same PCR conditions as in the first round, using the in-
ternal primers NNP1 forward primer (5′-GTGATAGTA
TCGAAAGGTAT-3′) and NP2 reverse primer (5′ACTC
TCTCTCAAATGTTCCT-3′) as previously described.
[32]. Positive controls (2 μLT. gondii DNA) and negative
controls (2 μL reagent grade H2O) were included in each
PCR run. The amplified products were visualized by
electrophoresis using 2% agarose gel in
Tris-Borate-EDTA (TBE) buffer (Promega, Madison,
USA) stained with 0.05% ethidium bromide for visual
detection by Ultraviolet Transilluminator (E-BOX, Vilber
Lournar France). PCR positivity for T. gondii was de-
fined by the presence of a 300-bp band on visualized in
the gel.
Statistical analysis
Data were analyzed using SPSS v.22 (IBM® Corp.,
Armonk, NY, USA). Descriptive data were reported as
frequencies, means, and medians. Categorical data are
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reported as tabulation of proportions. Logistic regression
analyses were used to examine associations between T.
gondii seropositivity (positive for IgM and/or IgG vs
negative for both) and candidate predictor variables.
Bivariable models were constructed for all candidate
demographic, behavioral, and awareness variables evalu-
ated. All variables with a coefficient p value ≤ 0.2 in the
bivariable model were considered in the multivariable
modeling [33]. Crude odds ratios (cORs) from bivariable
models and adjusted odds ratios (aORs) from the multi-
variable model are reported (Table 3).
Results
Demographic data
Samples and linked data were collected from 254 women
over a period of 60 days starting on 1 February 2017.
Among the 254 women who took part in this study, the
mean age in years was 29.9 years (SD ± 5.5) (Table 1).
The majority of participants, 158/254 (62.2%), resided in
Moshi Urban district in Kilimanjaro region. Most par-
ticipating women (74.8%) were educated beyond primary
school. The majority of the women (80.0%) were
employed and doing business/traders, with smaller pro-
portions being students, housewives and peasants (Table
1). Of the 254 pregnant women included in the study,
174 (68.5%) had one or more previous conceptions and
178 (70.1%) were in their third trimester of gestation at
the time of this survey. Results of HIV status from par-
ticipants’ files showed that 13 of 242 participants with
known HIV status (5.3%) were HIV positive. With regard
to knowledge of toxoplasmosis, 227 of the 254 women
(89.4%) reported that they had not heard about toxoplas-
mosis and 91.3% reported that they did not know about
its mode of transmission (Table 1).
Seroprevalence of T. gondii-specific IgG and IgM
antibodies
A total of 254 serum samples were tested for T. gondii-s-
pecific IgG and IgM antibodies. Serum samples from
113 women were seropositive for T. gondii-specific IgG
and/or IgM, giving an overall seroprevalence of 44.45%.
Of all tested samples, 102 (40.2%) and 23 (9.1%) were
seropositive for T. gondii-specific IgG and IgM anti-
bodies, respectively. Ten participants (3.9%) were posi-
tive for T. gondii-specific IgM but negative for T.
gondii-specific IgG and 77 (30.3%) participants were
positive for anti-T. gondii IgG but negative for T. gon-
dii-specific IgM (Table 2).
Factors associated with T. gondii seropositivity
In bivariable analysis, reported consumption of raw vegeta-
bles, regular soil contact, occupation, and education level
were associated with T. gondii seropositivity (Table 3). In
multivariable analysis, consumption of raw vegetables and
regular soil contact adjusted for participant’s occupation,
education, and HIV status were significantly associated with
T. gondii exposure. Participants who reported consumption
of raw vegetables were less likely to be seropositive for T.
gondii antibodies compared to those who were not con-
suming raw vegetables [aOR = 0.344; 95%CI 0.151–0.784; p
Table 1 Participant characteristics (n = 254)
Variables Frequency (n) Percentage (%)
Age group (years)
< 25 43 16.9
25–35 171 67.3
> 35 40 15.7
District of residence
Moshi Rural District 96 37.8
Moshi Urban District 158 62.2
Education level
Primary education 64 25.2
Secondary education 77 30.3
College/pre university education 45 17.7
University education 68 26.8
Occupation
Student 17 6.7
House wife 19 7.5
Farmer 15 5.9
Employed 91 35.8
Self-employed business women 112 44.1
Gravidity index
Primigravida 80 31.5
Multigravida 174 68.5
Trimester
1st trimester 10 3.9
2nd trimester 66 26.0
3rd trimester 178 70.1
HIV status
Positive 13 5.1
Negative 229 90.2
Not known 12 4.7
Heard about toxoplasmosis
Yes 27 10.6
No 227 89.4
Knowledge on toxoplasmosis routes of infection
Yes 22 8.7
No 232 91.3
Knowledge on effect of toxoplasmosis during pregnancy
Yes 14 5.5
No 240 94.5
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= 0.011]. The probability of exposure of participants who
had regular soil contact was lower than in those who did
not report regular contact with soil [aOR = 0.482; 95%CI
0.268–0.8681; p = 0.015].
Discussion
Toxoplasmosis is a parasitic infection of public health
importance. Efforts to determine its sero-epidemiology,
especially in high-risk groups such as pregnant women,
are important to understand the distribution and level of
exposure to this pathogen. These data can be useful for
the design of toxoplasmosis control and prevention
strategies. The current study was designed to determine
the seroprevalence and associated risk factors for expos-
ure to T. gondii among pregnant women in a Tanzanian
Table 2 Seropositivity of T. gondii-specific IgG and IgM
antibodies
IgG positivity IgM positivity
IgM +ve* IgM –ve IgM borderline Totals
IgG +ve* 12 (4.7) 77 (30.3) 13 (5.1) 102 (40.2%)
IgG –ve 10 (3.9) 131 (51.6) ** 3 (1.2) *** 144 (56.7%)
IgG borderline 1 (0.4) 7 (2.8) *** 8 (3.1%)
Totals 23 (9.1%) 215 (84.6%) 16 (6.3%) 254
Numbers indicate counts with respective percentages in parentheses. *All
samples in the row and column are positive (n = 113). **Negative (n = 131).
***Equivocal (n = 10)
Table 3 Logistic regression analyses of participant factors associated with T. gondii seropositivity
Variable Category Positive: n/N (%) Bivariable Multivariable
cOR 95% CI p value aOR 95%CI p value
Age groups < 25 20/43 (46.5) 1
25–35 72/171 (42.1) 0.836 0.427–1.637 0.602
> 35 21/40 (52.5) 1.271 0.536–3.012 0.586
Residence Rural 42/96 (43.8) 1
Urban 71/158 (44.9) 1.049 0.630–1.749 0.854
Education level Primary Education 33/64 (51.6) 1.431 0.806–2.541 0.221 1.478 0.727–3.005 0.281
≥ Secondary
education
80/190 (42.1) 1 1
Occupation Student 5/17 (29.4) 1 1
House wife 7/19 (36.8) 1.400 0.346–5.672 0.637 0.991 0.215–4.571 0.991
Famers 8/15 (53.3) 2.743 0.640–11.753 0.174 1.917 0.390–9.425 0.423
Employed 43/91 (47.3) 2.150 0.700–6.599 0.181 1.511 0.441–5.174 0.511
Business 50/112 (44.6) 1.935 0.639–5.860 0.243 1.742 0.542–5.595 0.351
HIV status Negative 100/229 (43.7) 1 1
Positive 7/13 (53.8) 0.676 0.220–2.075 0.494 0.699 0.220–2.223 0.544
Cat ownership Yes 20/39 (51.3) 1.355 0.684–2.683 0.384
No 93/254 (43.3) 1
Eating undercooked
meat
Yes 89/201 (44.3) 0.98 0.533–1.800 0.947
No 24/53 (45.3) 1
Eating raw vegetables Yes 92/221 (41.6) 0.415 0.195–0.886 0.023 0.344 0.151–0.784 0.011**
No 21/33 (63.6) 1 1
Eating unwashed fruits Yes 20/44 (45.5) 1.028 0.535–1.975 0.933
No 93/210 (44.3) 1
Water sources Tap water 104/237 (43.8) 0.803 0.292–2.211 0.671
Others 9/17 (52.9) 1
Regular soil contact Yes 74/181 (40.9) 0.617 0.357–1.066 0.083 0.482 0.268–0.868 0.015**
No 39/73 (53.4) 1 1
Habit of eating soil
(geophage)
Yes 20/49 (40.8) 0.788 0.433–1.434 0.435
No 93/205 (45.4) 1
cOR crude odds ratio, aOR adjusted odds ratio
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referral hospital. We observed a seroprevalence of 40.2%
based on T. gondii-specific IgG ELISA. This seropreva-
lence suggests endemicity of the parasitic infection in
the studied area in line with previous reports [26, 34].
Serological detection of T. gondii-specific IgM is an in-
dicator of recent or current infection [27]. In this study,
12 (4.7%) participants were positive for both T. gondii-s-
pecific IgM and IgG antibodies of which 10 (3.9%) were
T. gondii-specific IgM positive but T. gondii-specific IgG
negative. When the T. gondii-specific IgM-positive sam-
ples were subjected to PCR, none of them was positive
for T. gondii infection. This finding highlights the chal-
lenges of comparing serological and molecular diagnos-
tic test data and of obtaining samples that are appropriate
for PCR-based detection of T. gondii DNA. T. gondii-spe-
cific IgM test is used by most laboratories to determine if
a patient has been infected recently but T. gondii-specific
IgM antibodies may remain detectable for prolonged pe-
riods of time beyond the acute infection [35]. It is not sur-
prising therefore that positivity for T. gondii-specific IgM
in this study did not correspond with the PCR results gen-
erated. We used peripheral blood samples in this study
which are likely to have few circulating parasites [1, 7, 12].
In this regards, the diagnostic dilemma reported in this
study underscores the usefulness of relevant samples such
as amniotic fluid or placenta tissue for diagnosis of T. gon-
dii infection among pregnant women. Studies show that
although amniotic fluid or placenta samples might be
more relevant for the diagnosis of toxoplasmosis by PCR,
they have the disadvantage of additional sample process-
ing steps before processing the diagnosis.
In this study, more than two thirds of the studied
population had regular contact with soil (i.e., were in-
volved in activities such as gardening and farming). Pre-
vious studies have reported regular soil contact increases
the risk for T. gondii infection [36, 37]. However, our
findings show that participants who had regular soil
contact were less likely to be T. gondii seropositive, com-
pared to those who had no regular soil contact. This ob-
servation contradicts with the frequent finding of soil
contact being a risk factor for T. gondii infection. In this
study, participating women were mostly urban dwellers,
with a small proportion of the women participating in
farming activities as their primary occupation. The ex-
tent and nature of soil contact among women living in
town and those from rural areas could not be deter-
mined in this study.
The current study found that eating raw vegetables were
associated with reduced probability of T. gondii seroposi-
tivity. However, this protective effect is inconsistent with
that reported in Ethiopia [38] where consumption of raw
vegetables was associated with increased risk of T. gondii
infection. A possible explanation for our results has to do
with eating habits and food preparation practices in the
studied population. About half (44.9%) of participants in
this study had access to clean tap water which reduces the
likelihood for infection with T. gondii. Eighty percent of
the participants had post-primary school education which
suggests better understanding of hygiene principles. Simi-
lar to findings in this study, other studies have also re-
ported the absence of associations between consumption
of raw vegetables and T. gondii infection [39, 40].
Previous studies had reported that being rural dweller
[41], having low education/illiterate [42], eating under-
cooked meat [43], cat ownership [39, 40], drinking water
from public sources [38], and being HIV positive [44]
were all found to be risk factors for contracting T. gondii
infection. However, none of these factors had significant
association with T. gondii seropositivity in this study.
This may be explained by the fact that this was a
hospital-based study, involving a special group of preg-
nant women, who may not represent the wider commu-
nity. There is a need to conduct more studies that
involve pregnant women from different settings to estab-
lish and compare the T. gondii seroprevalence among
these different groups. There is also a need to conduct
longitudinal studies across seasons of the year to deter-
mine the seasonality of toxoplasmosis in pregnancy.
Conclusion
The current study reveals exposure to T. gondii infec-
tion and evidence of acute infection of T. gondii
among pregnant women in the study area. Addition-
ally, this study demonstrated low awareness of risk
factors for toxoplasmosis. Soil contact and eating raw
vegetables were the only factors associated with T.
gondii exposure. Our study was limited by the small
sample size and being a hospital-based cross-sectional
study which could have missed some important epi-
demiological associations. However, our findings pro-
vide a useful piece of evidence of exposure to T.
gondii among pregnant women.
Abbreviations
ANC: ante natal clinic; ELISA: Enzyme-Linked Immunosorbent Assay;
KCMC: Kilimanjaro Christian Medical Center
Acknowledgements
The authors acknowledge logistical and technical support from KCRI. We also
thank all the mothers who agreed to participate in this study.
Funding
This work was supported by the Leverhulme-Royal Society Africa Award
(AA130131).
Availability of data and materials
The datasets used and/or analyzed in this study may be made available from
the corresponding author on reasonable request.
Authors’ contributions
EP, IK, JH, and BM conceived the proposal idea and wrote the manuscript. EP
performed statistical analyses. AN and AM performed laboratory analyses of
samples. RN and ES participated in sample collection. JC wrote the
Paul et al. Tropical Medicine and Health           (2018) 46:39 Page 6 of 8
manuscript, assisted in the statistical analyses, and supervised the project. All
authors read and approved the final manuscript.
Ethics approval and consent to participate
This study was conducted after the approval of the Kilimanjaro Christian Medical
University College (KCMUCo) Research and Ethics Committee (Certificate #2224).
Permission to conduct the study was also obtained from Kilimanjaro Christian
Medical Center (KCMC) through the department of Obstetrics and Gynaecology.
Informed consent was obtained from all study participants.
Consent for publication
All authors approved and consented for the publication of this paper.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Kilimanjaro Christian Medical University College, P.O. Box 2240, Moshi,
Tanzania. 2Kilimanjaro Clinical Research Institute, P.O. Box 2236, Moshi,
Tanzania. 3Kilimanjaro Christian Medical Center, P.O. Box 3010, Moshi,
Tanzania. 4Boyd Orr Center for Population and Ecosystem Health, Institute of
Biodiversity, Animal Health and Comparative Medicine, College of Medical,
Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
Received: 11 May 2018 Accepted: 8 November 2018
References
1. Robert-Gangneux F, ML D+¬. Epidemiology of and diagnostic strategies for
toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264–96.
2. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of
Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005;6(1):
41–61.
3. Torgerson PR, Mastroiacovo P. The global burden of congenital
toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501–8.
4. Dubey JP. ToxoplasmosisΓÇôa waterborne zoonosis. Vet Parasitol. 2004;
126(1–2):57–72.
5. Dawson D. Foodborne protozoan parasites. Int J Food Microbiol. 2005;
103(2):207–27.
6. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–e1976 In:
CrossRef| PubMed| CAS| Web of Science-« Times Cited.
7. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis:
a review. Obstet Gynecol Surv. 2001;56(5):296–305.
8. Wilson CB, Nizet V, Remington JS, Klein JO, Maldonado Y. Infectious diseases
of the fetus and newborn E-Book. Philadelphia: Elsevier Health Sciences;
2010.
9. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM,
et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of
impact on fetal transmission and childrenΓÇÖs sequelae at age 1 year. Am J
Obstet Gynecol. 1999;180(2):410–5.
10. Pomares C, Montoya JG. Laboratory diagnosis of congenital toxoplasmosis. J
Clin Microbiol. 2016;54(10):2448–54.
11. Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis
of toxoplasmosis. J Clin Microbiol. 2004;42(3):941–5.
12. Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United
States: toxoplasmosis. Am J Trop Med Hyg. 2014;90(5):794–9.
13. Nash JQ, Chissel S, Jones J, Warburton F, Verlander NQ. Risk factors for
toxoplasmosis in pregnant women in Kent, United Kingdom. Epidemiol
Infect. 2005;133(3):475–83.
14. Gutierrez-Zufiaurre N, Sanchez-Hernandez J, Munoz S, Marin R, Delgado N,
Saenz MC, et al. Seroprevalence of antibodies against Treponema pallidum,
Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in
pregnant women. Enferm Infecc Microbiol Clin. 2004;22(9):512–6.
15. Jenum PA, Kapperud G, Stray-Pedersen B, Melby KK, Eskild A, Eng J.
Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies
among pregnant women in Norway. Epidemiol Infect. 1998;120(1):87–92.
16. Foroutan-Rad M, Khademvatan S, Majidiani H, Aryamand S, Rahim F, Malehi
AS. Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: a
systematic review and meta-analysis. Acta Trop. 2016;158:160–9.
17. Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M, et al.
Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol. 2003;
23(6):618–24.
18. Sitoe SP, Rafael B, Meireles LR, Andrade HF Jr, Thompson R. Preliminary
report of HIV and Toxoplasma gondii occurrence in pregnant women from
Mozambique. Rev Inst Med Trop Sao Paulo. 2010;52(6):291–5.
19. Al D, Ito LS, Coelho E, JM L+¦c, Matida LH, Ramos AN Jr. Seroprevalence of
Toxoplasma gondii IgG antibody in HIV/AIDS-infected individuals in
Maputo, Mozambique. Rev Saude Publica. 2013;47:890–6.
20. De Paschale M, Ceriani C, Cerulli T, Cagnin D, Cavallari S, Cianflone A, et al.
Antenatal screening for Toxoplasma gondii, Cytomegalovirus, rubella and
Treponema pallidum infections in northern Benin. Tropical Med Int Health.
2014;19(6):743–6.
21. Akinbami AA, Adewunmi AA, Rabiu KA, Wright KO, Dosunmu AO, Dada MO,
et al. Seroprevalence of Toxoplasma gondii antibodies amongst pregnant
women at the Lagos State University Teaching Hospital, Nigeria. Niger
Postgrad Med J. 2010;17(2):164–7.
22. Linguissi LSG, Nagalo BM, Bisseye C, Kagoné TS, Sanou M, Tao I, et al.
Seroprevalence of toxoplasmosis and rubella in pregnant women attending
antenatal private clinic at Ouagadougou, Burkina Faso. Asian Pac J Trop
Med. 2012;5(10):810–3.
23. Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect
Dis. 2012;44(11):805–14.
24. Yobi D, Piarroux R, L'Ollivier C, Franck J, Situakibanza H, Muhindo H, et al.
Toxoplasmosis among pregnant women: high seroprevalence and risk
factors in Kinshasa, Democratic Republic of Congo. Asian Pac J Trop
Biomed. 2014;4(1):69.
25. Swai E, Schoonman L. Seroprevalence of toxoplasma gondii infection
amongst residents of Tanga district in north-east Tanzania. Tanzan J Health
Res. 2009;11(4).
26. Doehring E, Reiter-Owona I, Bauer O, Kaisi M, Hlobil H, Quade G, et al.
Toxoplasma gondii antibodies in pregnant women and their newborns in
Dar es Salaam, Tanzania. Am J Trop Med Hyg. 1995;52(6):546–8.
27. Saajan AM, Nyindo M, Gidabayda JG, Abdallah MS, Jaffer SH, Mukhtar AG, et
al. TORCH Antibodies Among Pregnant Women and Their Newborns
Receiving Care at Kilimanjaro Christian Medical Center, Moshi, Tanzania.
Health Res J. 2017;95.
28. Machumi I, Mirambo MM, Ruganuza D, Rambau P, Massinde AN,
Kihunrwa A, et al. Factors associated with Toxoplasma gondii IgG and
IgM antibodies, and placental histopathological changes among women
with spontaneous abortion in Mwanza City, Tanzania. Health Res J.
2017;86.
29. Mitsunaga T, Larsen U. Prevalence of and risk factors associated with alcohol
abuse in Moshi, northern Tanzania. J Biosoc Sci. 2008;40(3):379–99.
30. Charles MP, Kweka EJ, Mahande AM, Barongo LR, Shekalaghe S, Nkya HM, et
al. Evaluation of uptake and attitude to voluntary counseling and testing
among health care professional students in Kilimanjaro region, Tanzania.
BMC Public Health. 2009;9(1):128.
31. Burrells A, Bartley PM, Zimmer IA, Roy S, Kitchener AC, Meredith A, et al.
Evidence of the three main clonal toxoplasma gondii lineages from wild
mammalian carnivores in the UK. Parasitology. 2013;140(14):1768–76.
32. Rouatbi M, Amdouni Y, Amairia S, Rjeibi MR, Sammoudi S, Rekik M, et
al. Molecular detection and phylogenetic analyses of Toxoplasma gondii
from naturally infected sheep in Northern and Central Tunisia. Vet Med
Sci. 2017;3(1):22–31.
33. Derksen S, Keselman HJ. Backward, forward and stepwise automated subset
selection algorithms: frequency of obtaining authentic and noise variables.
Br J Math Stat Psychol. 1992;45(2):265–82.
34. Mwambe B, Mshana SE, Kidenya BR, Massinde AN, Mazigo HD, Michael D, et
al. Sero-prevalence and factors associated with Toxoplasma gondii infection
among pregnant women attending antenatal care in Mwanza, Tanzania.
Parasit Vectors. 2013;6(1):222.
35. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and
toxoplasmosis. J Infect Dis. 2002;185(Supplement_1):S73–82.
36. Cook AJC, Holliman R, Gilbert RE, Buffolano W, Zufferey J, Petersen E, et al.
Sources of toxoplasma infection in pregnant women: European multicenter
case-control study commentary: congenital toxoplasmosisΓÇöfurther
thought for food. Bmj. 2000;321(7254):142–7.
Paul et al. Tropical Medicine and Health           (2018) 46:39 Page 7 of 8
37. Lopes-Mori FM, Mitsuka-Breganó R, Bittencourt LH, Dias RC, Gonçalves DD,
Capobiango JD, et al. Gestational toxoplasmosis in Paraná State, Brazil:
prevalence of IgG antibodies and associated risk factors. Braz J Infect Dis.
2013;17(4):405–9.
38. Bowie WR, King AS, Werker DH, Isaac-Renton JL, Bell A, Eng SB, et al.
Outbreak of toxoplasmosis associated with municipal drinking water.
Lancet. 1997;350(9072):173–7.
39. Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for
Toxoplasma infection among pregnant women in Aydin province, Turkey.
BMC Public Health. 2005;5(1):66.
40. Hung CS, Su HW, Lee YL, Weng HW, Wang YC, Naito T, et al.
Seroprevalence, seroconversion, and risk factors for toxoplasmosis among
pregnant women in Taipei, Taiwan. Jpn J Infect Dis. 2015;68(4):312–7.
41. Kamal AM, Ahmed AK, Abdellatif MZ, Tawfik M, Hassan EE. Seropositivity of
toxoplasmosis in pregnant women by ELISA at Minia University Hospital,
Egypt. Korean J Parasitol. 2015;53(5):605.
42. Agmas B, Tesfaye R, Koye DN. Seroprevalence of Toxoplasma gondii
infection and associated risk factors among pregnant women in Debre
Tabor, Northwest Ethiopia. BMC Res Notes. 2015;8(1):107.
43. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk
factors for Toxoplasma gondii infection in the United States. Clin Infect Dis.
2009;49(6):878–84.
44. Vidal JE, Hernandez AV, De Oliveira ACP, Dauar RF, Barbosa SP Jr, Focaccia R.
Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and
predictors of treatment response in the HAART era. AIDS Patient Care Stds.
2005;19(10):626–34.
Paul et al. Tropical Medicine and Health           (2018) 46:39 Page 8 of 8
